%20(1).png)
Life Sciences Queensland (LSQ), the leading voice for Queensland’s biotechnology and health innovation sector, and AusBiotech, Australia’s leading national industry body representing more than 3,000 life sciences members, have signed a Memorandum of Understanding (MOU) to deepen collaboration and advance Australia’s life sciences industry.
This agreement represents a strategic commitment to support the growth and resilience of Australia’s life sciences ecosystem. The MOU outlines an ambitious framework for cooperation, emphasising member engagement, knowledge exchange, and a unified approach to sector advocacy.
Professor Trent Munro, LSQ Board Chair, said:
“We welcome the opportunity to work more closely with AusBiotech to ensure that Queensland’s unique perspectives and opportunities are embedded into the national conversation about Australia’s biotechnology and medtech ecosystem.”
“We look forward to working more closely withAusBiotech and forging a “Team Australia” approach on the international stage.”
Dr Ryan Parlett, Acting CEO LSQ, said:
“It’s an exciting time for the biotechnology sector both nationally and in Queensland, with new companies setting up, and existing companies establishing a presence here, creating skilled jobs and economic return for the state.
“We are delighted to sign this MOU and look forward to strengthening our partnership and collaboration with AusBiotech.”
Dr James Campbell, Chair of AusBiotech, said:
“We look forward to deepening our collaboration with LSQ and building synergies that amplify our shared strengths. Now is the time to unite our voices, drawing on the remarkable innovation and talent across states like Queensland. Queensland is a thriving hub for cutting-edge developments in biotechnology.
"Together, we can create a more connected and collaborative sector.”
Rebekah Cassidy, CEO of AusBiotech, said:
“We are excited to announce this Memorandum of Understanding between AusBiotech and LSQ. It marks a significant step forward in uniting our efforts to drive growth and strengthen the life sciences ecosystem across Australia.
"By working together, we can leverage our combined strengths to advance research, support our members, and ultimately improve health outcomes for all Australians. Both of our organisations recognise the growing necessity to retain and nurture homegrown research, biotechnology, and medtech to protect against the evolving challenges of our global environment. Whether it’s climate change, future pandemic preparedness, pressures on supply chains and aging populations, we will be better prepared to support and grow the sector for the benefit of Australians if we work together.”
"I am so pleased we could sign this MOU at our AusBiotech Conference. I thank LSQ for their ongoing partnership and collaboration.”
About LSQ
Life Sciences Queensland is the peak industry body advancing Queensland’s life sciences sector by supporting health, biotech, and medtech innovation. The organisation connects stakeholders across industry, government, and academia, fostering an environment where collaboration drives the industry forward and strengthens Australia’s life sciences landscape.
About AusBiotech
AusBiotech is Australia's leading national and global advocate for life sciences, working to help its more than 3000 members thrive by shaping policy, creating connections, and fostering knowledge sharing. With an unrivalled national convening power, AusBiotech supports its members’ growth by building an Australian life sciences ecosystem that leads in development and commercialisation, creating high-quality, innovative life sciences companies.
-ENDS-
Media enquiries: Sally Dillon, Senior Communications Manager, Life Sciences Queensland, sdillon@lsq.com.au / M: +61(04) 425 751 900
Media enquiries: Emma Boscheinen, Director of Communications, AusBiotech, eboscheinen@ausbiotech.org/ M: +61 (0) 437 075 209
